Sun.Jun 23, 2024

article thumbnail

Weekend ICYMI: June 17 to June 21

Drug Topics

In case you missed it, this week we had news about migraine myths, the ongoing bird flu outbreak, improving vaccine hesitancy, and more.

Vaccines 186
article thumbnail

Opinion: The FDA needs to embrace phage therapy to help fight antimicrobial resistance

STAT

My daughter, Mallory, died in 2017 at the age of 25 from a multiply resistant bacterial lung infection that followed a double-lung transplant necessitated by cystic fibrosis. In the weeks before her death, my wife, Diane Shader Smith, and I sought out and obtained an innovative yet underused treatment for antibiotic-resistant bacteria known as phage therapy.

FDA 142
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Google-backed startup Heyday Health banks $12.5M to scale house calls combined with telehealth

Fierce Healthcare

Heyday Health launched three years ago to provide primary care to seniors by blending traditional house calls with 21st-century innovation via telehealth visits. | Heyday Health bills itself as a "virtual-forward, value-based care provider" designed to meet patients where they are, providing care in the comfort of their homes.

133
133
article thumbnail

Vertex islet cell therapy gets type 1 diabetics off insulin

pharmaphorum

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 were able to come off insulin within a year

115
115
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Teladoc research shows AI-powered 'nudges' can improve diabetes members' engagement, health outcomes

Fierce Healthcare

Artificial intelligence can play a key role in diabetes management programs by enabling more personalized health "nudges" for members, which drives higher engagement and better health outcomes, acc | Artificial intelligence can play a key role in diabetes management programs by enabling more personalized health "nudges" for members, which drives higher engagement and better health outcomes, according to new data released by Teladoc Health.

132
132
article thumbnail

FDA clears Argenx’ Vyvgart Hytrulo for rare disease CIDP

pharmaphorum

Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it hopes could find a use in more than a dozen diseases.

FDA 115

More Trending

article thumbnail

The PCAT Is Going Away, Will NAPLEX Pass Rates Fall?

Med Ed 101

How do you get better at something? Practice. At least that’s what I tell my kids. The (Pharmacy College Admissions Test) PCAT has gone away in 2024 and I can’t help but think that this will be another nail in the coffin of future high NAPLEX pass rates. The PCAT was a good avenue for […] The post The PCAT Is Going Away, Will NAPLEX Pass Rates Fall?

105
105
article thumbnail

Experts Discuss Serious Adverse Events for GLP-1 Medications

Pharmacy Times

Potential concerns surrounding GLP-include pancreatitis, pancreatic cancer, colorectal cancer, suicide and other phycological effects, and thyroid cancer.

111
111
article thumbnail

Top Resources for Pain Medicine Board Prep

Board Vitals - Pharmacist

Embarking on the journey to pass the Pain Medicine Certification Exam often presents a challenging endeavor, with many students grappling with questions such as “What resources should I use?” and “Where should I devote my time?” The prospect of passing the exam can seem overwhelming, yet success is attainable through a well-structured study plan and the utilization of appropriate resources.

93
article thumbnail

Implementing Community Health Workers into Pharmacy Reduces Health Equities, SDOH

Pharmacy Times

Adding a community health worker can improve the overall health equity for your patients.

109
109
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

High Throughput Phage Display for Accelerated Antibody Drug Discovery

BioPharm

Bio-Rad Laboratories, Inc., Pioneer™ Antibody Discovery Platform helps streamline the phage display-based discovery process and provides researchers with superior identification of high-quality therapeutic antibodies.

40
article thumbnail

Managing Diabetes and Cardiovascular Risk Through Collaborative Care

Pharmacy Times

Jennifer Goldman discusses the importance of collaborative care between providers like endocrinologists, cardiologists, primary care physicians, and pharmacists to manage diabetes and prevent cardiovascular events.

107
107
article thumbnail

DEA’s Expected Guidance: It Should Reduce Current “Pain” at the (Intrathecal Pain) Pump Dispensing Process and Improve Therapeutic Outcomes

The FDA Law Blog

By John A. Gilbert & Karla L. Palmer — For more than 50 years, the Drug Enforcement Administration (DEA) has enforced the central mandate of the Controlled Substances Act (CSA) to maintain a closed chain of distribution for drugs with a potential for abuse and diversion. The CSA and regulations promulgated by DEA are intended to reduce the potential for diversion and abuse and ensure that controlled substances are dispensed and delivered to patients for a legitimate medical purpose.

article thumbnail

Physician Calls for National Dialogue on Inequitable Access to Lifesaving GLP-1 Medications

Pharmacy Times

W. Timothy Garvey expressed concern over limited access to effective obesity medications like Ozempic due to shortages and high costs, urging stakeholders to work together on developing solutions.

105
105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Expert: Supporting Health Equity and Access to Care Through Community Pharmacies

Pharmacy Times

Niki Shah Vice President of Impact Innovation and Activation at McKesson, discusses efforts to advance health equity and access through community pharmacy initiatives.

article thumbnail

Expert: Semaglutide's Benefits in Obesity-Related Heart Failure, the Role of Pharmacists in Diabetes Care

Pharmacy Times

Semaglutide significantly improved heart failure symptoms and quality of life through weight loss and direct effects on heart tissue.

50